Cargando…

Clinicopathologic vs. Molecular Integrated Prognostication of Endometrial Carcinoma by European Guidelines

SIMPLE SUMMARY: The European Society of Gynaecological Oncology (ESGO), European Society for Radiotherapy and Oncology (ESTRO), and European Society of Pathology (ESP) published joint guidelines in January 2021 that provide recommendations on all relevant issues of diagnosis and treatment in endomet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Loukovaara, Mikko, Pasanen, Annukka, Bützow, Ralf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833335/ https://www.ncbi.nlm.nih.gov/pubmed/35158919 http://dx.doi.org/10.3390/cancers14030651

Ejemplares similares

Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Molecularly Classified Endometrial Carcinoma
por: Loukovaara, Mikko, et al.
Publicado: (2021)

Differential impact of clinicopathological risk factors within the 2 largest ProMisE molecular subgroups of endometrial carcinoma
por: Pasanen, Annukka, et al.
Publicado: (2021)

Interpretable prognostic modeling of endometrial cancer
por: Zagidullin, Bulat, et al.
Publicado: (2022)

Mismatch repair protein and MLH1 methylation status as predictors of response to adjuvant therapy in endometrial cancer
por: Loukovaara, Mikko, et al.
Publicado: (2021)

Clinical factors as prognostic variables among molecular subgroups of endometrial cancer
por: Kolehmainen, Anne, et al.
Publicado: (2020)

Low Expression of Stanniocalcin 1 (STC-1) Protein Is Associated With Poor Clinicopathologic Features of Endometrial Cancer
por: Khatun, Masuma, et al.
Publicado: (2021)

Testing for Lynch Syndrome in Endometrial Carcinoma: From Universal to Age-Selective MLH1 Methylation Analysis
por: Pasanen, Annukka, et al.
Publicado: (2022)

Altered glycosylation of glycodelin in endometrial carcinoma
por: Hautala, Laura C., et al.
Publicado: (2020)

FIGO 1988 versus 2009 staging for endometrial carcinoma: a comparative study on prediction of survival and stage distribution according to histologic subtype
por: Haltia, Ulla-Maija, et al.
Publicado: (2014)

Detection of microsatellite instability with Idylla MSI assay in colorectal and endometrial cancer
por: Ukkola, Iiris, et al.
Publicado: (2021)

Clinicopathological Prognostic Parameters of Endometrioid Endometrial Carcinomas
por: DROCAŞ, ILEANA, et al.
Publicado: (2022)

MED12 mutations and fumarate hydratase inactivation in uterine adenomyomas
por: Heikkinen, Tuomas, et al.
Publicado: (2018)

Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas
por: León‐Castillo, Alicia, et al.
Publicado: (2020)

Integration of Molecular Data in the Prognostic Stratification and Management of Endometrial Carcinoma
por: Raffone, Antonio, et al.
Publicado: (2022)

3′RNA and whole‐genome sequencing of archival uterine leiomyomas reveal a tumor subtype with chromosomal rearrangements affecting either HMGA2, HMGA1, or PLAG1
por: Jokinen, Vilja, et al.
Publicado: (2022)

3′RNA Sequencing Accurately Classifies Formalin-Fixed Paraffin-Embedded Uterine Leiomyomas
por: Mehine, Miika, et al.
Publicado: (2020)

Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practice
por: de Biase, Dario, et al.
Publicado: (2023)

The Clinicopathological Significance and Prognostic Value of Androgen Receptor in Endometrial Carcinoma: A Meta-Analysis
por: Wu, Xirong, et al.
Publicado: (2022)

Microcystic, elongated and fragmented (MELF) pattern in endometrial carcinoma: clinicopathologic analysis and prognostic implications
por: Song, Jinghua, et al.
Publicado: (2022)

Expression of mitochondrial transcription factor A in endometrial carcinomas: clinicopathologic correlations and prognostic significance
por: Toki, Naoyuki, et al.
Publicado: (2010)

Molecular subclass of uterine fibroids predicts tumor shrinkage in response to ulipristal acetate
por: Kolterud, Åsa, et al.
Publicado: (2022)

SPOP Inhibition of Endometrial Carcinoma and Its Clinicopathological Relationship
por: Zhu, Qing, et al.
Publicado: (2022)

Clinicopathological roles of adiponectin and leptin receptors in endometrial carcinoma
por: YABUSHITA, HIROMITSU, et al.
Publicado: (2014)

Global metabolomic profiling of uterine leiomyomas
por: Heinonen, Hanna-Riikka, et al.
Publicado: (2017)

Multiple clinical characteristics separate MED12-mutation-positive and -negative uterine leiomyomas
por: Heinonen, Hanna-Riikka, et al.
Publicado: (2017)

RON, ROR1 and SUSD2 expression in tissues of endometrial carcinoma patients. Clinicopathological and prognostic implications
por: Abdelbary, Abeer M., et al.
Publicado: (2022)

Clinicopathological and molecular pathological characteristics in tamoxifen‑related endometrial cancer
por: Saeki, Harumi, et al.
Publicado: (2023)

A novel uterine leiomyoma subtype exhibits NRF2 activation and mutations in genes associated with neddylation of the Cullin 3-RING E3 ligase
por: Mehine, Miika, et al.
Publicado: (2022)

Retracted: SPOP Inhibition of Endometrial Carcinoma and Its Clinicopathological Relationship
por: and Biomechanics, Applied Bionics
Publicado: (2023)

Clinicopathological features and prognostic significance of CTNNB1 mutation in low-grade, early-stage endometrial endometrioid carcinoma
por: Ruz-Caracuel, Ignacio, et al.
Publicado: (2021)

Prognostic Impact of Pathologic Features in Molecular Subgroups of Endometrial Carcinoma
por: Ruscelli, Martina, et al.
Publicado: (2023)

Clinicopathologic, molecular, and prognostic implications of the loss of EPCAM expression in colorectal carcinoma
por: Kim, Jung Ho, et al.
Publicado: (2015)

Clinicopathological and molecular characterization of high-grade endometrial carcinoma with POLE mutation: a single center study
por: Yu, Shuangni, et al.
Publicado: (2022)

Inherited mutations affecting the SRCAP complex are central in moderate-penetrance predisposition to uterine leiomyomas
por: Välimäki, Niko, et al.
Publicado: (2023)

Androgen receptor expression in endometrial carcinoma and its correlation with clinicopathologic features
por: Hashmi, Atif Ali, et al.
Publicado: (2018)

Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification
por: Karnezis, Anthony N, et al.
Publicado: (2017)

Clinicopathological and prognostic significance of pretreatment thrombocytosis in patients with endometrial cancer: a meta-analysis
por: Bai, Yi-Yang, et al.
Publicado: (2019)

Prognostic and Clinicopathological Role of PD-L1 in Endometrial Cancer: A Meta-Analysis
por: Lu, Ling, et al.
Publicado: (2020)

Prognostic Value of Clinicopathological Factors for Indonesian Breast Carcinomas of Different Molecular Subtypes
por: Widodo, Irianiwati, et al.
Publicado: (2017)

Microscopic colitis in Northern Ireland: an updated clinicopathological audit and assessment of compliance with European guidelines
por: Moore, Michelle, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3j1fckghe3j9cn691a1knh3qqp